Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Mylan Inc    

Financials ($)
Sales 2016 10 946 M
EBIT 2016 3 277 M
Net income 2016 2 070 M
Debt 2016 8 555 M
Yield 2016 -
Sales 2017 13 269 M
EBIT 2017 4 203 M
Net income 2017 2 709 M
Debt 2017 8 595 M
Yield 2017 -
P/E ratio 2016 11,66
P/E ratio 2017 9,07
EV / Sales 2016 2,73x
EV / Sales 2017 2,25x
Capitalization 21 320 M
More Financials
Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products.It operates through two segments: Generic and Specialty.The Generic pharmaceutical business is conducted primarily in the U.S. and... 
06/24Shareholder meeting
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on MYLAN INC
01:31p MYLAN NV : Launches Generic Apresoline® Injection
05/04 MYLAN NV : to Present at the Bank of America Merrill Lynch 19th Annual Health Ca..
05/03DJU.S. HOT STOCKS : Hot Stocks to Watch
05/03DJMylan Posts Better-Than-Expected Profit
05/03DJActivist Investor to Pressure Stada AG to Explore Potential Sale -- 2nd Updat..
05/03 MYLAN NV : Reports Strong First Quarter 2016 Earnings Results Including Total Re..
05/02DJActivist Investor to Pressure Stada AG to Explore Potential Sale -- Update
05/02DJActivist Investor to Pressure Stada AG to Explore Potential Sale Activist Inv..
More news
Sector news : Pharmaceuticals - NEC
04:02p ASTRAZENECA : Publication of a Prospectus
03:53pDJMERCK : Revenue Falls on Generic Competition, Currency -- Update
03:45p Sanofi ready to raise Medivation offer, could oust board
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 Mylan (MYL) Heather M. Bresch on Q4 2014 Results - Earnings Call Transcript
2015 Mylan Q4 revenues up 15%, Specialty up 38%
2015 Mylan (MYL) Q4 2014 Results - Earnings Call Webcast
2015 Mylan EPS in-line, beats on revenue
2015 Notable earnings after Monday?s close
Duration : Period :
Mylan Inc Technical Analysis Chart | US6285301072 | 4-Traders
Full-screen chart
Technical analysis trends MYLAN INC
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions